Higher Uveitis Risk in Cancer Patients on BRAF Inhibitors

BRAF inhibitors raise the risk for uveitis in patients with skin melanoma or lung cancer compared with conventional cytotoxic drugs or immune checkpoint inhibitors.
Medscape Medical News